ID

34544

Descripción

3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH; ODM derived from: https://clinicaltrials.gov/show/NCT02207868

Link

https://clinicaltrials.gov/show/NCT02207868

Palabras clave

  1. 19/1/19 19/1/19 -
  2. 22/5/19 22/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

19 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Pulmonary Arterial Hypertension NCT02207868

Eligibility Pulmonary Arterial Hypertension NCT02207868

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >17
Descripción

ID.1

Tipo de datos

boolean

pulmonary arterial hypertension (pah) associated with who group 1 who start a parenteral prostanoid-therapy
Descripción

ID.2

Tipo de datos

boolean

written informed consent
Descripción

ID.3

Tipo de datos

boolean

prostanoid naive
Descripción

ID.4

Tipo de datos

boolean

no change of the pah specific therapy within 3 weeks of the recruitment to the study
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and lactation period
Descripción

ID.6

Tipo de datos

boolean

women of child bearing potential who do not use an effective and secure method for birth control
Descripción

ID.7

Tipo de datos

boolean

severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
Descripción

ID.8

Tipo de datos

boolean

liver-insufficiency child c
Descripción

ID.9

Tipo de datos

boolean

life expectancy shorter than the course of the study (for example because of malignant disease
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Pulmonary Arterial Hypertension NCT02207868

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age >17
boolean
ID.2
Item
pulmonary arterial hypertension (pah) associated with who group 1 who start a parenteral prostanoid-therapy
boolean
ID.3
Item
written informed consent
boolean
ID.4
Item
prostanoid naive
boolean
ID.5
Item
no change of the pah specific therapy within 3 weeks of the recruitment to the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnancy and lactation period
boolean
ID.7
Item
women of child bearing potential who do not use an effective and secure method for birth control
boolean
ID.8
Item
severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
boolean
ID.9
Item
liver-insufficiency child c
boolean
ID.10
Item
life expectancy shorter than the course of the study (for example because of malignant disease
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial